Evolution Towards Omnichannel Engagement in Market Access

This document is a report that discusses the evolution of omnichannel engagement strategies in market access, particularly in the context of the pharmaceutical industry. It outlines the challenges faced by market access stakeholders due to digital environments, budget constraints, and the shift towards value-based healthcare. The report highlights the significant investment in digital engagement, particularly in North America, where approximately $1.3 billion is spent annually. It notes that despite a global increase in digital channel investment, a small percentage is allocated to market access. The report emphasizes the importance of tailored, data-driven digital engagement strategies, especially since the pandemic has increased reliance on digital resources among payers. It details key tenets of effective omnichannel marketing, including personalized communication, a unified brand experience, and the use of data-driven insights to enhance payer engagement. The document concludes by emphasizing the potential for collaboration between pharma companies and payers to optimize access and improve patient outcomes.